Epigral Limited — Board Meeting, 09-11-2024: Outcome of Board Meeting

Epigral Limited announced the approval of its un-audited financial results for the second quarter and half-year ending September 30, 2024. Revenue increased to ₹626.06 crore, while net profit was reported at ₹80.53 crore. The company also informed about the issuance of shares under a Qualified Institutional Placement, raising ₹333.05 crores. The firm, formerly known as Meghmani Finechem Limited, continues to focus on manufacturing Chiaro Alkali and its derivatives.